Siarhei Vysotski1, Casey Madura2, Benjamin Swan3, Ryan Holdsworth1, Yunzhi Lin4, Alejandro Munoz Del Rio1,5, Joel Wood6, Bornali Kundu7, Amy Penwarden8, Jed Voss1, Thomas Gallagher9, Veena A Nair1, Aaron Field1,10, Camille Garcia-Ramos5, Elizabeth M Meyerand10,5, Mustafa Baskaya2, Vivek Prabhakaran1, John S Kuo11,12. 1. Department of Radiology, University of Wisconsin-Madison, School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792-3252. 2. Neurological Surgery, University of Wisconsin-Madison, School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792-3252. 3. Department of Radiology, Mount Auburn Hospital, 330 Mount Auburn Street, Cambridge, MA 02138. 4. Department of Statistics, University of Wisconsin Madison, 1300 University Avenue, Madison, WI 53705. 5. Department of Medical Physics, University of Wisconsin-Madison, Wisconsin Institutes for Medical Research (WIMR), 1111 Highland Avenue Rm 1005, Madison, WI 53705. 6. Department of General Surgery, UW Hospitals and Clinics, 600 Highland Avenue, Madison, WI 53792-3252. 7. Medical Scientist Training Program, University of Wisconsin Madison, 6001 Research Park Blvd. Rm 1056, Madison, WI 51719. 8. Department of Anesthesiology, University of North Carolina -Chapel Hill, 106 Bel Arbor Ln Carrboro, NC 27510. 9. Department of Radiology, Northwestern University Feinberg School of Medicine, NMH/Arkes Family Pavilion Suite 800, 676 N Saint Clair, Chicago IL 60611. 10. Biomedical Engineering, University of Wisconsin-Madison, 1550 Engineering Dr, Madison, WI 53706, USA. 11. UW Carbone Cancer Center, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792, USA. 12. UW Center for Stem Cell and Regenerative Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, K3/803 Clinical Science Center, Mail Code 8660, 600 Highland Avenue, Madison, WI 53792-3252.
Abstract
BACKGROUND: Functional Magnetic Resonance Imaging (fMRI) is a presurgical planning technique used to localize functional cortex so as to maximize resection of diseased tissue and avoid viable tissue. In this retrospective study, we examined differences in morbidity and mortality of brain tumor patients who received preoperative fMRI in comparison to those who did not. METHODS: Brain tumor patients (n=206) were selected from a retrospective review of neurosurgical case logs from 2001-2009 at the University of Wisconsin-Madison. RESULTS: Univariate analysis showed improved mortality in the fMRI group and the fMRI+Electrical Cortical Stimulation Mapping (ECM) group compared to the No-fMRI group. Multivariate analyses showed improved mortality of the fMRI group and the fMRI+ECM group compared to the No-fMRI group, with age and tumor grade being the most significant influencers. Overall, the fMRI group showed survival benefits at 3 years; twice that of the No-fMRI group. Furthermore, patients with high-grade tumors showed significant survival benefits in the fMRI group, while patients with low-grade tumors did not (controlling for age and ECM). There was also a significant difference in the two groups with respect to morbidity, with patients receiving fMRI showing improved outcomes in the motor and language domains. CONCLUSIONS: This study analyzing a large retrospective series of brain tumor patients with and without the use of fMRI in the preoperative planning has resulted in improved mortality and morbidity outcomes with the use of fMRI. These results point to the importance of incorporating fMRI in presurgical planning in the clinical management of patients with brain tumors.
BACKGROUND: Functional Magnetic Resonance Imaging (fMRI) is a presurgical planning technique used to localize functional cortex so as to maximize resection of diseased tissue and avoid viable tissue. In this retrospective study, we examined differences in morbidity and mortality of brain tumor patients who received preoperative fMRI in comparison to those who did not. METHODS: Brain tumor patients (n=206) were selected from a retrospective review of neurosurgical case logs from 2001-2009 at the University of Wisconsin-Madison. RESULTS: Univariate analysis showed improved mortality in the fMRI group and the fMRI+Electrical Cortical Stimulation Mapping (ECM) group compared to the No-fMRI group. Multivariate analyses showed improved mortality of the fMRI group and the fMRI+ECM group compared to the No-fMRI group, with age and tumor grade being the most significant influencers. Overall, the fMRI group showed survival benefits at 3 years; twice that of the No-fMRI group. Furthermore, patients with high-grade tumors showed significant survival benefits in the fMRI group, while patients with low-grade tumors did not (controlling for age and ECM). There was also a significant difference in the two groups with respect to morbidity, with patients receiving fMRI showing improved outcomes in the motor and language domains. CONCLUSIONS: This study analyzing a large retrospective series of brain tumor patients with and without the use of fMRI in the preoperative planning has resulted in improved mortality and morbidity outcomes with the use of fMRI. These results point to the importance of incorporating fMRI in presurgical planning in the clinical management of patients with brain tumors.
Authors: J Hirsch; M I Ruge; K H Kim; D D Correa; J D Victor; N R Relkin; D R Labar; G Krol; M H Bilsky; M M Souweidane; L M DeAngelis; P H Gutin Journal: Neurosurgery Date: 2000-09 Impact factor: 4.654
Authors: F J Lagerwaard; P C Levendag; P J Nowak; W M Eijkenboom; P E Hanssens; P I Schmitz Journal: Int J Radiat Oncol Biol Phys Date: 1999-03-01 Impact factor: 7.038
Authors: M Lacroix; D Abi-Said; D R Fourney; Z L Gokaslan; W Shi; F DeMonte; F F Lang; I E McCutcheon; S J Hassenbusch; E Holland; K Hess; C Michael; D Miller; R Sawaya Journal: J Neurosurg Date: 2001-08 Impact factor: 5.115
Authors: Francesco Pignatti; Martin van den Bent; Desmond Curran; Channa Debruyne; Richard Sylvester; Patrick Therasse; Denes Afra; Philippe Cornu; Michel Bolla; Charles Vecht; Abul B M F Karim Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff Journal: N Engl J Med Date: 2005-03-10 Impact factor: 91.245
Authors: Matteo Mancini; Sjoerd B Vos; Vejay N Vakharia; Aidan G O'Keeffe; Karin Trimmel; Frederik Barkhof; Christian Dorfer; Salil Soman; Gavin P Winston; Chengyuan Wu; John S Duncan; Rachel Sparks; Sebastien Ourselin Journal: Neuroimage Clin Date: 2019-05-28 Impact factor: 4.881
Authors: Katharina Hense; Tina Plank; Christina Wendl; Frank Dodoo-Schittko; Elisabeth Bumes; Mark W Greenlee; Nils Ole Schmidt; Martin Proescholdt; Katharina Rosengarth Journal: Cancers (Basel) Date: 2021-05-18 Impact factor: 6.639
Authors: Sauson Soldozy; Daniel K Akyeampong; David L Barquin; Pedro Norat; Kaan Yağmurlu; Jennifer D Sokolowski; Khadijeh A Sharifi; Petr Tvrdik; Min S Park; M Yashar S Kalani Journal: Front Surg Date: 2020-09-30